<?xml version="1.0" encoding="ISO-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="http://www.buytestosterones.net/testosterone-article-feed/androgel/">
        <title>Buy Testosterones</title>
        <description>'Androgel'</description>
        <link>http://www.buytestosterones.net/androgel/</link>
       <dc:date>2008-10-11T13:08:09+01:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros-therapeutics-inc.-initiates-a-comparative-phase-2b-study-of-oral-androxal&amp;#174;-as-compared-to-topical-testim&amp;#174;-examining-effects-on-male-fertility..."/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#adverse-event-reporting-news----androgel--1%"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros-therapeutics-inc.-reports-second-quarter-2007-financial-results"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros'-androxal-shows-highly-statistically-significant-positive-effects-in-men-with-secondary-hypogonadism"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#chain-drug-review----fda-first-time-generics-approvals"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----zacks-bull-and-bear-of-the-day-highlights:-trident-microsystems,-auxilium-pharmaceuticals,-progressive-corporation-and-parker-hannifin"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----research-and-markets:-fenofibrate-is-solvay-pharmaceuticals-flagship-product-and-principal-growth-driver"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros'-androxal-shows-noninferiority-in-interim-phase-3-analysis"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----zacks-bull-and-bear-of-the-day-highlights:-acusphere,-auxilium-pharmaceuticals,-wintrust-financial-and-united-microelectronics"/>
                <rdf:li rdf:resource="http://www.buytestosterones.net/testosterone-article/androgel/#biotech-patent-news----watson-and-unimed-settle-lawsuit-over-testosterone-gel."/>
            </rdf:Seq>
        </items>
    </channel>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros-therapeutics-inc.-initiates-a-comparative-phase-2b-study-of-oral-androxal&amp;#174;-as-compared-to-topical-testim&amp;#174;-examining-effects-on-male-fertility...">
        <dc:format>text/html</dc:format>
        <title>Business Wire -  Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal&amp;amp;#174; as Compared to Topical Testim&amp;amp;#174; Examining Effects on Male Fertility...</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros-therapeutics-inc.-initiates-a-comparative-phase-2b-study-of-oral-androxal&amp;#174;-as-compared-to-topical-testim&amp;#174;-examining-effects-on-male-fertility...</link>
        <description>June 30, 2008 -- Provides Guidance on Proellex Endometriosis Phase 2 Data and Initiation of Androxal Phase 2b Study for the Treatment of Hyperglycemia   THE...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#adverse-event-reporting-news----androgel--1%">
        <dc:format>text/html</dc:format>
        <title>Adverse Event Reporting News -  AndroGel  1%</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#adverse-event-reporting-news----androgel--1%</link>
        <description>May 6, 2008 -- CONTRAINDICATIONS   AndroGel should not be used in any of the following patients:   * Men with carcinoma of the breast or known or suspected...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros-therapeutics-inc.-reports-second-quarter-2007-financial-results">
        <dc:format>text/html</dc:format>
        <title>Business Wire -  Repros Therapeutics Inc. Reports Second Quarter 2007 Financial Results</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros-therapeutics-inc.-reports-second-quarter-2007-financial-results</link>
        <description>August 8, 2007 -- THE WOODLANDS, Texas -- Repros Therapeutics (NasdaqGM: RPRX) today announced financial results for the three-month and six-month periods ended June...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros'-androxal-shows-highly-statistically-significant-positive-effects-in-men-with-secondary-hypogonadism">
        <dc:format>text/html</dc:format>
        <title>Business Wire -  Repros' Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros'-androxal-shows-highly-statistically-significant-positive-effects-in-men-with-secondary-hypogonadism</link>
        <description>June 5, 2007 -- Non-Inferiority to Market Leading Drug Demonstrated in Six Month Study   THE WOODLANDS, Texas -- Repros Therapeutics Inc. (NasdaqGM:RPRX) announced...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#chain-drug-review----fda-first-time-generics-approvals">
        <dc:format>text/html</dc:format>
        <title>Chain Drug Review -  FDA first-time generics approvals</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#chain-drug-review----fda-first-time-generics-approvals</link>
        <description>February 19, 2007 -- FDA First-Time Generics Approvals--2006GENERIC DRUG NAME         MANUFACTURER             BRAND NAMEJANUARYIsradipine capsules       Abrika...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----zacks-bull-and-bear-of-the-day-highlights:-trident-microsystems,-auxilium-pharmaceuticals,-progressive-corporation-and-parker-hannifin">
        <dc:format>text/html</dc:format>
        <title>Business Wire -  Zacks Bull and Bear of the Day Highlights: Trident Microsystems, Auxilium Pharmaceuticals, Progressive Corporation and Parker Hannifin</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----zacks-bull-and-bear-of-the-day-highlights:-trident-microsystems,-auxilium-pharmaceuticals,-progressive-corporation-and-parker-hannifin</link>
        <description>January 26, 2007 -- CHICAGO -- Zacks Equity Research highlights Trident Microsystems, Inc. (Nasdaq: TRID) as the Bull of the Day and Auxilium Pharmaceuticals (Nasdaq:...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----research-and-markets:-fenofibrate-is-solvay-pharmaceuticals-flagship-product-and-principal-growth-driver">
        <dc:format>text/html</dc:format>
        <title>Business Wire -  Research and Markets: Fenofibrate is Solvay Pharmaceuticals Flagship Product and Principal Growth Driver</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----research-and-markets:-fenofibrate-is-solvay-pharmaceuticals-flagship-product-and-principal-growth-driver</link>
        <description>January 12, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c48366) has announced the addition of the Espicom Business...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros'-androxal-shows-noninferiority-in-interim-phase-3-analysis">
        <dc:format>text/html</dc:format>
        <title>Business Wire -  Repros' Androxal Shows Noninferiority in Interim Phase 3 Analysis</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----repros'-androxal-shows-noninferiority-in-interim-phase-3-analysis</link>
        <description>December 20, 2006 -- THE WOODLANDS, Texas -- Repros Therapeutics Inc. (NasdaqGM:RPRX)(PCX:RPRX) announced interim results of a U.S. Phase 3 study of Androxal[TM], an oral...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----zacks-bull-and-bear-of-the-day-highlights:-acusphere,-auxilium-pharmaceuticals,-wintrust-financial-and-united-microelectronics">
        <dc:format>text/html</dc:format>
        <title>Business Wire -  Zacks Bull and Bear of the Day Highlights: Acusphere, Auxilium Pharmaceuticals, Wintrust Financial and United Microelectronics</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#business-wire----zacks-bull-and-bear-of-the-day-highlights:-acusphere,-auxilium-pharmaceuticals,-wintrust-financial-and-united-microelectronics</link>
        <description>December 13, 2006 -- CHICAGO -- Zacks Equity Research highlights Acusphere, Inc. (Nasdaq: ACUS) as the Bull of the Day and Auxilium Pharmaceuticals (Nasdaq: AUXL) as the...</description>
    </item>
    <item rdf:about="http://www.buytestosterones.net/testosterone-article/androgel/#biotech-patent-news----watson-and-unimed-settle-lawsuit-over-testosterone-gel.">
        <dc:format>text/html</dc:format>
        <title>BIOTECH Patent News -  Watson and Unimed settle lawsuit over testosterone gel.</title>
        <link>http://www.buytestosterones.net/testosterone-article/androgel/#biotech-patent-news----watson-and-unimed-settle-lawsuit-over-testosterone-gel.</link>
        <description>September 1, 2006 -- Watson Pharmaceuticals, Inc. (Corona, CA), a leading specialty  pharmaceutical company, announced that it has reached a settlement with  Unimed...</description>
    </item>
</rdf:RDF>
